# Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)

> **NCT00656370** · PHASE4 · COMPLETED · sponsor: **Halozyme Therapeutics** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** recombinant human hyaluronidase

## Key facts

- **NCT ID:** NCT00656370
- **Lead sponsor:** Halozyme Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-01-30
- **Final completion:** 2008-01-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656370, "Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00656370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*